BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Lack of Sufficient Data Sinks Atara in Mid-Phase MS Study

  Atara announced that it has completed an interim analysis of its Phase II EMBOLD trial for the use of its candidate ATA188 in patients with progressive multiple sclerosis.

  July 13, 2022

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Business

  Amazon Forays into Life Sciences with Fred-Hutch Partnered Cancer Vaccine

  In what seems like an unlikely collaboration, Seattle-based Fred Hutchinson Cancer Center (Fred Hutch) is partnering with Amazon to develop cancer vaccines.

  July 13, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Employer Resources

  Sanofi, Pfizer and More Use Upskilling to Solve the Life Science Talent Shortage

  Sanofi, Certara, Pfizer and Thermo Fisher are facing hiring challenges head-on with a common strategy: upskilling programs. They use these programs to fill open roles while training and retaining existing talent.

  July 13, 2022

   · 

  7 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  NIH Study Unable to Confirm Benefit of Humanigen’s Lenzilumab in COVID-19

  An NIH-sponsored trial assessing a combination of Humanigen’s lenzilumab and Gilead Sciences’ remdesivir in hospitalized COVID-19 patients failed to achieve the primary endpoint.

  July 13, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  NYU Surgeons Successfully Implant Two Pig Hearts into Brain-Dead Patients

  Physicians at New York University have successfully implanted pig hearts into the bodies of patients that were living but no longer showed neural function, a process called xenotransplantation.

  July 13, 2022

   · 

  3 min read

   · 

  Jazmine Colatriano M.S.
• 

  Policy

  Opioid Crisis and Settlements: Where We are Today

  BioSpace takes a look at some of the recent legal battles and settlements related to the opioid epidemic across the industry.

  July 13, 2022

   · 

  4 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Amgen Expands Lumakras into Lung Cancer, Hints at Positive Data Coming Soon

  Early data from Amgen’s ongoing trial on Lumakras for non-small cell lung cancer hinted at positive results from what could be a transformative combination of drugs versus cancer.

  July 13, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Novel Peptide Could Create Pathway Against Insulin Resistance in Type 2 Diabetes

  A multinational research collaboration has developed a new peptide dubbed “PATAS”, which appears to fix the metabolic abnormalities leading to type 2 diabetes (T2D).

  July 13, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Money on the Move: Pfizer Backs Mystery Company, Teva/AbbVie Settle Opioid Suits

  Gossamer Bio sold shares of its common stock to pave its runway through mid-2024 while Teva and AbbVie reach deals in opioid settlements.

  July 13, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  Study: Hyperbaric Oxygen Therapy may Improve Cognitive Function in Long COVID

  Aviv Clinics reported data from a study that suggests hyperbaric oxygen therapy may alleviate long COVID symptoms, particularly those associated with cognition.

  July 13, 2022

   · 

  2 min read

   · 

  Alex Keown